Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Bring tissues and skip the mascara: The movie that's making theater-goers sob uncontrollaby - 2Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- 34 Energy-Proficient Clothes washers to Consider in 2024
- 4Visiting This Japanese City Just Got A Little More Expensive (Here's What Travelers Should Know)
- 5Winter storm headed for Midwest to Northeast. Here's how much snow to expect.
- Former Peruvian President Pedro Castillo sentenced for conspiracy
- Vote in favor of your Favored kind of craftsmanship
- The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior
- 6 U.S. States for Climbing
- The Best Web-based Courses for Ability Advancement
- Like many holiday traditions, lighting candles and fireplaces is best done in moderation
- Manual for Tracking down One of a kind Store Inns
- Heart disease risk greater for women with a common condition they may not be aware they have
- 'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action
